Drug-Drug Interaction Study of Evobrutinib and Transporter Substrates
Clinical trial NCT05064488 · COMPLETED
Trial details
- NCT number
- NCT05064488
- Sponsor
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-04
- Primary completion
- 2021-12-10
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.